SALT Dental Partners Acquires Ashmore Orthodontics
SALT Dental Partners, a portfolio company of Dallas-based Latticework Capital Partners, announced that it expanded its portfolio with the acquisition of Ashmore Orthodontics. Ashmore Orthodontics operates out of two locations in Washington: Port Orchard and Bremerton. According to its website, there is one physician on staff (Dr. Jennifer Ashmore). Headquartered in Phoenix, Arizona, SALT Dental Partners is a dental partnership organization specializing in specialty pediatric dentistry and orthodontics. It has more than 90 locations across 13 states nationwide. Marking SALT’s 12th acquisition of the year, this deal strengthens SALT’s footprint in the Pacific... Read More »
The Carlyle Group Acquires Tarrytown Expocare Pharmacy from Sheridan Capital Partners
On November 14, The Carlyle Group announced that it was purchasing Tarrytown Expocare Pharmacy from Sheridan Capital Partners for an undisclosed amount. Tarrytown Expocare Pharmacy is a long-term care specialty pharmacy focused exclusively on serving the intellectual and developmental disability and behavioral health communities. Beginning with services in 2007 to 150 individuals in the Tarrytown section of Austin, Texas, the company has grown to provide services in 36 states from 12 regional pharmacies. The Carlyle Group is one of the world’s largest private equity firms. It manages more than $465 billion of assets under management, as of June 30, 2025. Carlyle employs... Read More »
PE Firm Linden Capital Partners Buys Agape Care Group
Linden Capital Partners has acquired Spartanburg, South Carolina-headquartered Agape Care Group from Ridgemont Equity Partners for an undisclosed amount. As a regional leader in hospice and palliative care, Agape Care Group’s more than 2,100 employees provide hospice and palliative care to more than 5,700 patients daily across 10 states. Ridgemont Equity Partners previously acquired the company from the private equity firm The Vistria Group in 2019. Linden Capital Partners is a Chicago-based healthcare private equity firm exclusively focused on leveraged buyouts in the healthcare and life science industries. The Agape acquisition took place in July 2025 but was not publicly... Read More »
JSR Life Sciences to Transfer Crown Bioscience to Adicon Holdings Limited
JSR Life Sciences LLC, a global leader in life sciences materials and services, announced it has entered into a definitive agreement to transfer Crown Bioscience Inc. to Adicon Holdings Limited. The deal will enable Crown Bioscience to operate as a standalone entity under Adicon’s ownership. The transaction, subject to customary closing conditions, is expected to close in 2026. Financial terms were not disclosed. Crown Bioscience is a contract research organization (CRO) specializing in oncology and immuno-oncology drug discovery and development. The company has a comprehensive portfolio of translational oncology services, including its patient-derived xenograft models, tumor... Read More »
